<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) patients with <z:e sem="disease" ids="C1332128" disease_type="Neoplastic Process" abbrv="">peritoneal carcinomatosis</z:e> (PC) have a poor prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>Over the last decade, increasing evidence has suggested that the Collagen Triple Helix Repeat Containing 1 (CTHRC1) gene is involved in <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">cancer progression</z:e> and invasion </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we investigated the expression of CTHRC1 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and its potential as a prognostic factor for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients with PC </plain></SENT>
<SENT sid="3" pm="."><plain>Microarray analysis of four fresh paired samples showed that the expression of CTHRC1 in <z:e sem="disease" ids="C0346989" disease_type="Neoplastic Process" abbrv="">peritoneal metastases</z:e> was higher than that in the corresponding <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>These results were validated using semi-quantitative reverse transcription and polymerase chain reaction </plain></SENT>
<SENT sid="5" pm="."><plain>Finally, immunohistochemical analysis showed that CTHRC1 was increased in the peritoneal <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> group (n = 30) and the primary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> with peritoneal <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> group (n = 57) compared to the primary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> without peritoneal <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> group (n = 54), both P &lt; 0.001 </plain></SENT>
<SENT sid="6" pm="."><plain>Cox proportional hazards model analysis showed that high CTHRC1 expression was associated with poor survival (HR = 2.754, P &lt; 0.001, 95 % CI 1.731-4.383) </plain></SENT>
<SENT sid="7" pm="."><plain>Overall, the results of our study suggest that increased expression of CTHRC1 is associated with PC in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients and could predict poor outcome in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
</text></document>